Evidence map›Paper›PMID 30959909›Full record

ArticleInternational journal of molecular sciences2019

Bioreactor-Controlled Physoxia Regulates TGF-β Signaling to Alter Extracellular Matrix Synthesis by Human Chondrocytes.

Holger Jahr, Seval Gunes, Annika-Ricarda Kuhn, Sven Nebelung, Thomas Pufe

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Strategies to Modulate the Redifferentiation of Chondrocytes.Frontiers in bioengineering and biotechnology · 2021
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Holger JahrInstitute of Anatomy and Cell Biology, University Hospital Aachen, 52072 Aachen, Germany. hjahr@ukaachen.de.ORCID 0000-0001-7308-5584
Seval GunesInstitute of Anatomy and Cell Biology, University Hospital Aachen, 52072 Aachen, Germany. sevalguness@gmail.com.
Annika-Ricarda KuhnInstitute of Anatomy and Cell Biology, University Hospital Aachen, 52072 Aachen, Germany. annikakuhn.kuhn@alumni.maastrichtuniversity.nl.ORCID 0000-0002-0163-7738
Sven NebelungDepartment of Diagnostic and Interventional Radiology, Aachen University Hospital, 52072 Aachen, Germany. snebelung@ukaachen.de.
Thomas PufeInstitute of Anatomy and Cell Biology, University Hospital Aachen, 52072 Aachen, Germany. tpufe@ukaachen.de.ORCID 0000-0002-7886-9211
Universitätsklinikum Aachen · DEMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Culturing articular chondrocytes under physiological oxygen tension exerts positive effects on their extracellular matrix synthesis. The underlying molecular mechanisms which enhance the chondrocytic phenotype are, however, still insufficiently elucidated. The TGF-β superfamily of growth factors, and the prototypic TGF-β isoforms in particular, are crucial in maintaining matrix homeostasis of these cells. We employed a feedback-controlled table-top bioreactor to investigate the role of TGF-β in microtissues of human chondrocytes over a wider range of physiological oxygen tensions (i.e., physoxia). We compared 1%, 2.5%, and 5% of partial oxygen pressure (pO₂) to the 'normoxic' 20%. We confirmed physoxic conditions through the induction of marker genes (

Indexed as

AggrecansBioreactorsChondrocytesCollagen Type IICollagen Type IIIExtracellular MatrixHumansHypoxia-Inducible Factor-Proline DioxygenasesProtein IsoformsSignal TransductionSmad1 ProteinSmad2 ProteinSmad3 ProteinSmad5 ProteinSmad8 ProteinSOX9 Transcription FactorACAN protein, humanAggrecansCOL2A1 protein, humanCOL3A1 protein, humanCollagen Type IICollagen Type IIIEGLN3 protein, humanHypoxia-Inducible Factor-Proline DioxygenasesProtein IsoformsSmad1 ProteinSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanSmad5 ProteinSMAD5 protein, humanSmad8 ProteinSMAD9 protein, humanSOX9 protein, humanSOX9 Transcription FactorTGFB2 protein, humanTransforming Growth Factor betaTransforming Growth Factor beta2Vascular Endothelial Growth Factor AALK1, ALK5betaglycanchondrocytic marker expressionendoglinphysiological oxygenphysoxiaSp1/3TGF-β receptors, type I, type II, type IIITGF-β superfamily

Identifiers

PMID30959909
PMCPMC6480267
OpenAlexW2930595179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.